Bernedette Lynne Rohl, PA-C

Bernedette Rohl practices at Guthrie Corning Hospital in Corning, New York, part of The Guthrie Clinic.

Bernedette Rohl's NPI, 1154394732, was assigned on February 13, 2006. Bernedette Rohl holds New York license 005825-1.

Bernedette Rohl's primary practice is Guthrie Corning Hospital, at 1 Guthrie Drive, Corning, NY 14830 in Steuben County. The practice phone is (607) 937-7200.

Bernedette Rohl's primary practice is Guthrie Corning Hospital in Corning, New York, part of The Guthrie Clinic. The medical group on file is Guthrie Medical Group. Dmand AI also links Bernedette Rohl to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Bernedette Rohl practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Bernedette Rohl's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Bernedette Rohl is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Bernedette Rohl is licensed in New York.

Dmand AI lists acute sinusitis, acute skin infection, anxiety, arthritis, asthma, bipolar disorder, bronchitis and bursitis among the conditions Bernedette Rohl treats.

CMS data shows 312 Medicare services from Bernedette Rohl across 5 procedure codes in 2024, for 106 Medicare patients. Medicare paid $10,438 for them. Every service was in an office.

CMS counts 106 Medicare patients who saw Bernedette Rohl in 2024. The largest group is 65 to 74, with 47 patients. 74% of them have high cholesterol, and 66% have high blood pressure. 22% are also on Medicaid. Their average risk score is 0.83, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Bernedette Rohl's median patient age at 35, with 98% women.

In 2024, Bernedette Rohl wrote 4,370 Medicare Part D claims for 341 patients. 87% of them were for generic drugs. CMS names the drug for 3,703 of them, across 83 drugs with 11 or more claims each, at $266,712 in total drug cost.

Bernedette Rohl accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 3 general payments to Bernedette Rohl from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. SPR Therapeutics, Inc paid the most, $68.